Azamollugin, a mollugin derivative, has inhibitory activity on MyD88- and TRIF-dependent pathways

Yuki Nakajima(Fujisawa City Hospital), Hiroshi Morita(Hoshi University), Alfarius Eko Nugroho(Hoshi University), Kazunori Takahashi(Hoshi University), Yusuke Hirasawa(Hoshi University), Hitomi Nishino(Hoshi University), Toshio Kaneda(Osaka City General Hospital)
Journal of Natural Medicines
September 16, 2024
Cited by 4


Related Papers